Long-Term Oncologic Outcomes, Opioid Use, and Complications after Esophageal Cancer Surgery
Open accessThe DOI matches its Crossref record; 22 of the 24 references it cites were found in a registry or an index.
Abstract
Effective and adequate opioid use and prevention of postoperative complications are important for enhanced recovery after surgery. We examined the effects of postoperative opioid use and postoperative complications on overall survival and recurrence-free survival after esophageal cancer surgery. This retrospective cohort study analyzed the records of patients diagnosed with esophageal cancer who underwent the Ivor Lewis operation between January 2005 and December 2011. We collected data on total opioid use for 8 days postoperatively, as well as information on postoperative complications (Clavien-Dindo classification). One hundred and twenty-one patients were included in the final analysis. Total opioid use was not significantly associated with overall survival (p = 0.520) and recurrence-free survival (p = 0.818). In contrast, the hazard ratio of postoperative overall survival was significantly higher with respect to Clavien-Dindo classification 1–2 (hazard ratio: 2.009, p = 0.046), 3a–3b (hazard ratio: 5.759, p < 0.001), and 4a–5 (hazard ratio: 3.982, p = 0.020) complications compared to no complications. Additionally, the hazard ratio of the recurrence-free survival was significantly higher in class 1–2 complications (hazard ratio: 2.336, p = 0.028) compared to none. Our study demonstrates that postoperative opioid use is not associated with survival and recurrence-free survival after esophageal cancer surgery, while postoperative complications may increase the hazard ratio for survival and recurrence-free survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Furthermore, squamous carcinoma is the most common pathogenic form of esophageal cancer in China [18].Its growth rate and pathological changes are diferent from those of adenocarcinoma [19], so the patient may experience diverse symptoms and thus interpret them variously.”
From Symptom Experiences before Medical Help-Seeking and Psychosocial Responses of Patients with Esophageal Cancer: A Qualitative Study. (2023) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Clavien-Dindo Classification of Surgical Complications: Five-Year Experience
Clavien, P. A., Barkun, J., de Oliveira, M. L., Vauthey, J. N., Dindo, D., Schulick, R. D., de Santibañes, E., Pekolj, J., Slankamenac, K., Bassi, C., et al. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b13ca2 · Cited by 11,482 · cited 1×
“Postoperative complications were classified according to severity via the Clavien-Dindo classification (7 grades: 1, 2, 3a, 3b, 4a, 4b, and 5) [10].”
MethodEnzinger, P. C., & Mayer, R. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035010 · Cited by 2,509
Epidemiology of esophageal cancer
Zhang, Y. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i34.5598 · Cited by 984
Immune Dysfunction as a Cause and Consequence of Malnutrition
Bourke, C. D., Berkley, J. A., & Prendergast, A. J. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.04.003 · Cited by 725 · cited 1×
“Further, immune dysfunction caused by malnutrition as a result of various postoperative complications [19] may also be a contributing factor.”
BackgroundMarkar, S., Gronnier, C., Duhamel, A., Mabrut, J.-Y., Bail, J.-P., Carrere, N., Lefevre, J. H., Brigand, C., Vaillant, J.-C., Adham, M., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001011 · Cited by 320 · cited 3×
“Postoperative complications using this classification were found to have an impact on patient OS or RFS in two previous studies [7,8], and our findings support the findings of these studies.”
BackgroundResultLerut, T., Moons, J., Coosemans, W., Van Raemdonck, D., De Leyn, P., Decaluwé, H., Decker, G., & Nafteux, P. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181bdd5a8 · Cited by 272 · cited 3×
“Postoperative complications using this classification were found to have an impact on patient OS or RFS in two previous studies [7,8], and our findings support the findings of these studies.”
BackgroundResultThe Effects of Postoperative Pain Management on Immune Response to Surgery
Beilin, B., Shavit, Y., Trabekin, E., Mordashev, B., Mayburd, E., Zeidel, A., & Bessler, A. H. (2003) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000078586.82810.3b · Cited by 251 · cited 1×
“First, postoperative complications may induce immunosuppressive effects via the stress response to more severe postoperative pain [18] and through immunosuppression caused by increased opioid use [6].”
BackgroundEsophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up
Stahl, M., Budach, W., Meyer, H., & Cervantes, A. M. R. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq163 · Cited by 138
Cata, J. P., Keerty, V., Keerty, D., Feng, L., Norman, P. H., Gottumukkala, V. N. R., Mehran, J., & Engle, M. (2014) · Cancer Medicine · doi:10.1002/cam4.236 · Cited by 136 · cited 2×
“These findings are in contrast with those of previous studies that suggested an association between opioid use and cancer recurrence [13,14].”
BackgroundResultMaher, D. P., Wong, W., White, P. F., McKenna, R., Rosner, H. L., Shamloo, B., Louy, C., Wender, R. H., Yumul, R., & Zhang, V. (2014) · British Journal of Anaesthesia · doi:10.1093/bja/aeu192 · Cited by 104 · cited 1×
“These findings are in contrast with those of previous studies that suggested an association between opioid use and cancer recurrence [13,14].”
Result
Research works printed but not linked: 1
- Jacox, 1994, Management of cancer pain-adults, Am. Fam. Physician, 49, 1853
Cited by
He, Y., Liang, D., Du, L., Guo, T., Liu, Y., Sun, X., Wang, N., Zhang, M., Wei, K., Shan, B., et al. (2020) · 癌症:英文版 · doi:10.1002/cac2.12087 · Cited by 120
“F IGURE 1 Distribution of the participating hospitals comprising of provincial (blue color), and municipal and county (orange color) hospitals Therefore, the aim of this study was to use a large number of multicenter cases to determine the lifestyle and clinical risk factors related to the survival of EC patients in C…”
BackgroundInfluentialOh, T. K., Kim, K., Jheon, S., Lee, J., Do, S.-H., Hwang, J., & Song, I. (2018) · Cancer Control · doi:10.1177/1073274818775360 · Cited by 94
“However, we reported recently that remifentanil dosage during surgery was not clinically associated with OS or RFS in esophageal cancer surgery.(18) In summary, issues regarding the impact of epidural analgesia or opioid use on OS or RFS in lung cancer are still questionable.”
BackgroundSelf-citationAnesthetic Approaches and Their Impact on Cancer Recurrence and Metastasis: A Comprehensive Review
Choi, H., & Hwang, W. (2024) · Cancers · doi:10.3390/cancers16244269 · Cited by 57
Zheng, J., He, J., Wang, W., Zhou, H., Cai, S., Zhu, L., Qian, X., Wang, J., Lu, Z., & Huang, C. (2020) · Medicine · doi:10.1097/md.0000000000019306 · Cited by 45
Díaz‐Cambronero, Ó., Mazzinari, G., Giner, F., Belltall, A., Ruiz-Boluda, L., Marí, A. M., Sánchez‐Guillén, L., Eroles, P., Cata, J. P., & Argente-Navarro, M. P. (2020) · Cancers · doi:10.3390/cancers12010134 · Cited by 27
“While it decreased survival on early stages of lung cancer [38] had no impact on colorectal or esophageal cancers [30,39,40].”
BackgroundLoeser, H., Kraemer, M., Gebauer, F., Bruns, C. J., Schröder, W., Zander, T., Alakus, H., Hoelscher, A. H., Buettner, R., Lohneis, P., et al. (2020) · Journal of Immunology Research · doi:10.1155/2020/2862647 · Cited by 12
“Esophageal cancer is associated with the sixth highest cancer-related mortality rate and a median survival time of 29 months [1, 2].”
Impact of co-morbidity on reoperation or death within 90 days of surgery for oesophageal cancer
Cheng, Z., Johar, A. M., Gottlieb‐Vedi, E., Nilsson, M., Lagergren, J., & Lagergren, P. (2021) · BJS Open · doi:10.1093/bjsopen/zraa035 · Cited by 11
Tong, C., Cao, H., Xu, Y., Li, D., Zhang, H., Xu, M., Luo, Y., & Wu, J. (2021) · World Journal of Surgery · doi:10.1007/s00268-021-06081-9 · Cited by 10
Ma, Y., Ren, J., Chen, Z., Chen, J., Wei, M., Wang, Y., Chen, H., & Wang, L. (2023) · BMC Anesthesiology · doi:10.1186/s12871-023-02023-1 · Cited by 7
Ge, H., Zhang, L., Ma, X., Li, W., & Li, S. (2023) · European Journal of Cancer Care · doi:10.1155/2023/6506917 · Cited by 5
“Furthermore, squamous carcinoma is the most common pathogenic form of esophageal cancer in China [18].”
Hu, C., Zhang, S., Chen, Q., & Wang, R. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/4752609 · Cited by 3
RetractedZhang, Y., Chen, Q., Chen, X., Zhang, M., Li, P., Huang, Z., Zhao, H., & Wu, H. (2022) · Journal of Cancer · doi:10.7150/jca.74674 · Cited by 3
“A large number of clinical studies have focused on the effect of perioperative opioid consumption on the prognosis of patients, and yielded conflicting results for various types of cancer [4-9].”
ResultZhang, Y., Shi, X., Wang, Y., Wang, R., Lin, F., Cao, Y., Li, W., & Chen, H. (2026) · eLife · doi:10.7554/elife.109982.1 · Cited by 2
Song, P., Ye, J., Zhang, H., Li, Y., Cao, R., Feng, Y., Zhang, L., & Sun, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1572810 · Cited by 1
Gao, M., Zhao, B., Yang, W., Tang, J., & Liu, Y. (2023) · PubMed Central · doi:10.12122/j.issn.1673-4254.2023.11.13 · Cited by 2
Hasegawa‐Moriyama, M., & Kanmura, Y. (2020) · Open Journal of Anesthesiology · doi:10.4236/ojanes.2020.104009 · Cited by 1
“Although the correlation between intraoperative opioid use and survival has not been clarified, postoperative opioid use was recently demonstrated not to be associated with survival and recurrence-free survival after esophageal cancer surgery, while postoperative complications may increase the hazard ratio for surviva…”
BackgroundZhang, Y., Shi, X., Wang, Y., Wang, R., Lin, F., Cao, Y., Li, W., & Chen, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.06.658288 · Cited by 1
Saeed, I., Caze, A. L., Shaw, P. N., & Parat, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-69584-8.00012-8
Zhang, Y., Shi, X., Wang, Y., Wang, R., Lin, F., Cao, Y., Li, W., & Chen, H. (2026) · eLife · doi:10.7554/elife.109982 · Cited by 1
eIF6 affects the occurrence and development of esophageal cancer
Huang, C.-G., Zhou, X., Huang, R., Zhang, H.-L., Li, C., Du, F., Lei, H., Dai, Q., & Yang, Z. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12268-x
Metadata
- Authors
- Oh, T. K., Kim, K., Jheon, S. H., Do, S.-H., Hwang, J.-W., Jeon, Y.-T., Kim, K., & Song, I.-A.
- Affiliations
- Seoul National University (KR)
- Seoul National University Bundang Hospital (KR)
- Corresponding author
- Song, In-Ae
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2018-02-19
- Volume
- 7
- Issue
- 2
- Pages
- 33
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC5852449
- OpenAlex
- W2792539867
- Cited by
- 20
- References
- 24
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 5 · 2018: 1
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Health Sciences › Medicine › Surgery › Enhanced Recovery After Surgery
- Keywords
- esophageal cancer, postoperative opioid use, postoperative complications, Clavien-Dindo classification, overall survival, recurrence-free survival, enhanced recovery after surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.